MICROBOT MEDICAL INC. (NASDAQ:MBOT) Files An 8-K Other Events
Item 8.01.
|
Other Events
|
announcing that the U.S. Patent and Trademark Office has issued a
Notice of Allowance for a key technology patent covering a device
for the prevention of shunt stenosis. A copy of the press release
is attached as Exhibit 99.1 to this Current Report on Form 8-K
and incorporated herein by reference.
|
Item 9.01
|
Financial Statements and Exhibits
|
||||
|
Exhibit
|
Description
|
||||
|
99.1
|
Press Release dated February 22, 2017
|
||||
About MICROBOT MEDICAL INC. (NASDAQ:MBOT)
Microbot Medical Inc., formerly StemCells, Inc., is a medical device company. The Company specializes in the researching, designing, developing and commercializing transformational micro-robotic medical technologies leveraging the artificial and natural lumens within the human body. It is engaged in developing its two product candidates: the Self Cleaning Shunt (SCS) for the treatment of hydrocephalus and normal pressure hydrocephalus (NPH), and TipCAT, a self-propelling, semi-disposable endoscope that the Company is developing for use in colonoscopy procedures. Its ViRob technology is an autonomous crawling micro-robot, which can be controlled remotely or within the body. The Microbot SCS device is a robotic system designed as the ventricular catheter portion of a cerebrospinal fluid (CSF) shunt system. The Company’s TipCAT is an endoscope that provides see and treat capabilities within tubular lumens in the human body, such as the colon, blood vessels and the urinary tract. MICROBOT MEDICAL INC. (NASDAQ:MBOT) Recent Trading Information
MICROBOT MEDICAL INC. (NASDAQ:MBOT) closed its last trading session down -0.26 at 6.05 with 1,822,079 shares trading hands.